Posted by Site Administrator on June 6, 2012
The parent molecule, DHA, is available in stores, although it has not been tested in clinical trials for ALS. Studies with DHA are in progress for Alzheimer’s disease, stroke and brain injury and have been mostly positive.
Categories: Research News, Technology, Treatments
|
Tags: 501(c)(3) ALS charity, ALS, ALS community, ALS research, amyotrophic lateral sclerosis, Bob Stehlin, breakthrough, DHA ALS, DHA neuroprotective ALS, IL-6, immune cells ALS, inflammation ALS, inflammatory proteins ALS, lipid mediator resolvin D1, Lou Gehrig's disease, macrophage ALS, MND, motor neurone diseases, motor neurons ALS, omega-3 fatty acid DHA, RASCALS Foundation, resolvin D1, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig’s Disease amotrophic lateral sclerosis, UCLA
|
No comments